Condition: Gastric Adenocarcinoma · Esophageal Adenocarcinoma · Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
To investigate the effects of the combination of two chemotherapies followed by immunostimulants on the interferon gamma expression and infiltration of cytotoxic T cells in the tumour microenvironment in patients with previously untreated metastatic or locally advanced esophagogastric cancer.
This description comes directly from the study's public registry record.
Joris Bos, MSc · 0204440506 · j.bos3@amsterdamumc.nl
Always discuss trial participation with your own doctor first.
| Academic Medical Center, Medical Oncology | Amsterdam, Netherlands | Recruiting |
| Amsterdam UMC, location VUmc | Amsterdam, Netherlands | Recruiting |
| Catharina ziekenhuis | Eindhoven, Netherlands | Recruiting |
| Medisch Centrum Leeuwarden | Leeuwarden, Netherlands | Not Yet Recruiting |
| LUMC | Leiden, Netherlands | Not Yet Recruiting |
| Radboud UMC | Nijmegen, Netherlands | Recruiting |
| Erasmus MC | Rotterdam, Netherlands | Not Yet Recruiting |
| UMC Utrecht | Utrecht, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05177133